blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3632426

EP3632426 - AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER ACTIVITY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.08.2023
Database last updated on 15.06.2024
FormerRequest for examination was made
Status updated on  09.10.2020
FormerThe application has been published
Status updated on  06.03.2020
Most recent event   Tooltip08.05.2024New entry: Despatch of examination report + time limit 
Applicant(s)For all designated states
Pharma Cinq, LLC
1601 Research Boulevard
Rockville, MD 20850 / US
[2024/23]
Former [2020/15]For all designated states
Wellstat Therapeutics Corporation
14200 Shady Grove Road, Suite 600
Rockville, MD 20850 / US
Inventor(s)01 / SIMPSON, David M.
6611 Sulky Lane
North Bethesda, MD Maryland 20852 / US
02 / ZERBY, Dennis Bryan
11733 Crystal Falls Drive
Smithsburg, MD 21783 / US
03 / LU, Ming
13518 Broadfield Drive
Bethesda, MD Maryland 20854 / US
04 / VON BORSTEL, Reid W.
10017 Sorrel Avenue
Potomac, MD Maryland 20854 / US
05 / LI, Rui
16179 Black Rock Road
Darnestown, MD Maryland 20874 / US
06 / READING, Julian
1509 Scotts Chase Drive
Frederick, MD Maryland 21702 / US
07 / WOLPE, Stephen
18301 Clear Smoke Road
Boyds, MD Maryland 20841 / US
08 / AMAN, Nureddin
1478 Kingstream Drive
Herndon, VA Virginia 20170 / US
 [2020/16]
Former [2020/15]01 / SIMPSON, David M.
6611 Sulky Lane
North Bethesda, MD Maryland 20852 / US
02 / ZERBY, Dennis Bryan
8651 Fort Mccord Road
Chambersburg, PA Pennsylvania 17202 / US
03 / LU, Ming
13518 Broadfield Drive
Bethesda, MD Maryland 20854 / US
04 / VON BORSTEL, Reid W.
10017 Sorrel Avenue
Potomac, MD Maryland 20854 / US
05 / LI, Rui
16179 Black Rock Road
Darnestown, MD Maryland 20874 / US
06 / READING, Julian
1509 Scotts Chase Drive
Frederick, MD Maryland 21702 / US
07 / WOLPE, Stephen
18301 Clear Smoke Road
Boyds, MD Maryland 20841 / US
08 / AMAN, Nureddin
1478 Kingstream Drive
Herndon, VA Virginia 20170 / US
Representative(s)Mathys & Squire
The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2020/15]Gregson, Anna Louise
Mathys & Squire LLP The Shard
32 London Bridge Street
London
SE1 9SG / GB
Application number, filing date19201890.131.01.2014
[2020/15]
Priority number, dateUS201361759512P01.02.2013         Original published format: US 201361759512 P
[2020/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3632426
Date:08.04.2020
Language:EN
[2020/15]
Search report(s)(Supplementary) European search report - dispatched on:EP31.01.2020
ClassificationIPC:A61K31/337
[2020/15]
CPC:
C07D471/04 (EP,IL,US); A61P29/00 (EP,RU); C07D215/40 (EP,IL,KR,US);
A01N43/42 (IL,US); A01N43/50 (IL,US); A01N43/54 (IL,US);
A01N43/60 (IL,US); A01N43/90 (IL,US); A61K31/337 (EP,IL,US);
A61K31/40 (EP,IL,US); A61K31/4164 (EP,IL,US); A61K31/4184 (EP,IL,US);
A61K31/437 (EP,IL,US); A61K31/44 (EP,IL,US); A61K31/4425 (EP,IL,US);
A61K31/4706 (EP,IL,KR,US); A61K31/4709 (EP,IL,US); A61K31/472 (EP,IL,US);
A61K31/4745 (EP,IL,US); A61K31/475 (EP,IL,US); A61K31/4965 (EP,IL,US);
A61K31/498 (EP,IL,US); A61K31/505 (EP,IL,US); A61K31/517 (EP,IL,RU,US);
A61K31/555 (EP,IL,US); A61K31/704 (EP,IL,US); A61P31/10 (EP,RU);
A61P33/02 (EP,IL,US); A61P35/00 (EP,IL,RU,US); C07D209/12 (EP,IL,US);
C07D213/73 (EP,IL,US); C07D213/74 (EP,IL,US); C07D215/38 (EP,IL,KR,US);
C07D215/42 (EP,IL,US); C07D215/44 (EP,IL,US); C07D215/46 (EP,IL,US);
C07D233/60 (EP,IL,US); C07D235/08 (EP,IL,US); C07D239/42 (EP,IL,US);
C07D239/94 (EP,IL,RU,US); C07D241/20 (EP,IL,US); C07D241/44 (EP,IL,US);
C07D401/12 (EP,IL,US); A61K2300/00 (IL); Y02A50/30 (EP,US);
Y02P20/582 (EP,US) (-)
C-Set:
A61K31/337, A61K2300/00 (US,EP);
A61K31/40, A61K2300/00 (EP,US);
A61K31/4164, A61K2300/00 (US,EP);
A61K31/4184, A61K2300/00 (EP,US);
A61K31/437, A61K2300/00 (EP,US);
A61K31/4425, A61K2300/00 (US,EP);
A61K31/44, A61K2300/00 (EP,US);
A61K31/4706, A61K2300/00 (US,EP);
A61K31/4709, A61K2300/00 (US,EP);
A61K31/472, A61K2300/00 (US,EP);
A61K31/4745, A61K2300/00 (US,EP);
A61K31/475, A61K2300/00 (US,EP);
A61K31/4965, A61K2300/00 (EP,US);
A61K31/498, A61K2300/00 (US,EP);
A61K31/505, A61K2300/00 (EP,US);
A61K31/517, A61K2300/00 (US,EP);
A61K31/555, A61K2300/00 (US,EP);
A61K31/704, A61K2300/00 (US,EP)
(-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/46]
Former [2020/15]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:AMINVERBINDUNGEN MIT ENTZÜNDUNGSHEMMENDER, FUNGIZIDER, ANTIPARASITÄRER UND ANTIKREBSWIRKUNG[2020/15]
English:AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC AND ANTICANCER ACTIVITY[2020/15]
French:COMPOSÉS D'AMINE PRÉSENTANT UNE ACTIVITÉ ANTI-INFLAMMATOIRE, ANTIFONGIQUE, ANTIPARASITAIRE ET ANTICANCÉREUSE[2020/15]
Examination procedure06.10.2020Amendment by applicant (claims and/or description)
06.10.2020Examination requested  [2020/46]
06.10.2020Date on which the examining division has become responsible
07.05.2024Despatch of a communication from the examining division (Time limit: M04)
Parent application(s)   TooltipEP14746786.4  / EP2950649
Fees paidRenewal fee
08.10.2019Renewal fee patent year 03
08.10.2019Renewal fee patent year 04
08.10.2019Renewal fee patent year 05
08.10.2019Renewal fee patent year 06
27.01.2020Renewal fee patent year 07
28.06.2021Renewal fee patent year 08
27.06.2022Renewal fee patent year 09
28.07.2023Renewal fee patent year 10
26.01.2024Renewal fee patent year 11
Penalty fee
Additional fee for renewal fee
31.01.202108   M06   Fee paid on   28.06.2021
31.01.202209   M06   Fee paid on   27.06.2022
31.01.202310   M06   Fee paid on   28.07.2023
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption31.03.2023Interruption of proceedings. Reason: legal prevention of applicant[2024/11]
02.05.2024Resumption of proceedings[2024/11]
Documents cited:Search[X]US4213987  (FUJII KATSUTOSHI [JP], et al) [X] 1,5,6,9,12 * compound 1, 2, 34, 91, 92, 96, 167, 217, 259, 274 *;
 [X]US4331667  (SCHNEIDER RUPERT) [X] 1-4 * column 1, line 56-66; table in column 2 *;
 [X]EP0520722  (ICI PLC [GB]) [X] 1,2,9,11 * table I, compound 1 and 4 *;
 [X]WO9609294  (WELLCOME FOUND [GB], et al) [X] 1,2,9-11 * page 1, 1st paragraph; example 22, 39, 41, 44, 46, 49, 51 *;
 [X]US6046206  (PAMUKCU RIFAT [US], et al) [X] 1,2,9,11 * example 59; column 1, line 9-10 *;
 [X]WO2012079079  (HARVARD COLLEGE [US], et al) [X] 1,2,7,9-11* paragraph bridging page 1 and 2; page 20-24 *;
 [A]  - FIRESTONE R A ET AL, "LYSOSOMOTROPIC AGENTS. 7.1 BROAD-SPECTRUM ANTIFUNGAL ACTIVITY OF LYSOSOMOTROPIC DETERGENTS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19870101), vol. 30, no. 8, doi:10.1021/JM00391A043, ISSN 0022-2623, pages 1519 - 1521, XP002050360 [A] 1-14 * table I-III *

DOI:   http://dx.doi.org/10.1021/jm00391a043
 [A]  - MAHADEO A. SUKHAI ET AL, "Lysosomal disruption preferentially targets acute myeloid leukemia cells and progenitors", JOURNAL OF CLINICAL INVESTIGATION, US, (20121203), vol. 123, no. 1, doi:10.1172/JCI64180, ISSN 0021-9738, pages 315 - 328, XP055278810 [A] 1-14 * table 2; figure 4 *

DOI:   http://dx.doi.org/10.1172/JCI64180
 [A]  - RAYMOND FIRESTONE, "Lysosomotropic Agents. 1. Synthesis and Cytotaxic Action of Lysosomotropic Detergents", JOURNAL OF MEDICINAL CHEMISTRY, (19790901), vol. 22, no. 9, pages 1130 - 1133, XP055279491 [A] 1-14 * paragraph bridging page 1130 and 1131 *
 [A]  - SASHI NADANACIVA ET AL, "A high content screening assay for identifying lysosomotropic compounds", TOXICOLOGY IN VITRO., GB, (20101222), vol. 25, no. 3, doi:10.1016/j.tiv.2010.12.010, ISSN 0887-2333, pages 715 - 723, XP055279409 [A] 1-14 * table 2; figure 4; page 722, left hand column, 1st full paragraph *

DOI:   http://dx.doi.org/10.1016/j.tiv.2010.12.010
 [X]  - SERGIY I. KOVALENKO, "Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)[1,2,4]triazolo[1,5-c]quinazolines", SCIENTIA PHARMACEUTICA, Austria, (20130101), vol. 81, no. 2, doi:10.3797/scipharm.1211-08, ISSN 0036-8709, pages 359 - 391, XP055658898 [X] 1,5,9,11 * compound 3.35, 3.40, 3.41 *

DOI:   http://dx.doi.org/10.3797/scipharm.1211-08
by applicant   - ALFORD JGSTANLEY PLTODDERUD GTRAMPOSCH KM, "Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester", Agents Actions, (19920000), vol. 37, no. 3-4, pages 260 - 7
    - SWINDELL WRJOHNSTON ACARBAJAL SHAN GWOHN CLU JXING XNAIR RPVOORHEES JJELDER JT, "Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis", PLoS One, (20110000), vol. 6, no. 4, page e18266
    - VAN DER FITS LMOURITS SVOERMAN JSKANT MBOON LLAMAN JDCORNELISSEN FMUS AMFLORENCIA EPRENS EP, "Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis", J Immunol., (20090000), vol. 182, no. 9, doi:doi:10.4049/jimmunol.0802999, pages 5836 - 45, XP055376245

DOI:   http://dx.doi.org/10.4049/jimmunol.0802999
    - SRIKANTA, D et al., "Cryptococcus neoformans infection", PLoS ONE, (20110000), vol. 6, no. 7, page e22773
    - HARRISON, T. S et al., "Cryptococcus neoformans", J Infect Disease, (20000000), vol. 182, pages 283 - 289
    - CANTON EPEMAN JVIUDES AQUINDOS GGOBERNADO MESPINEL-INGROFF A, "Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species", Diagn Microbiol Infect Dis., (20030000), vol. 45, pages 203 - 6
    - GHANNOUM MAISHAM N, "Voriconazole and Caspofungin Cidality Against Non-Albicans Candida Species", Infectious Diseases in Clinical Practice, (20070000), vol. 15, no. 4, pages 250 - 253
    - ISHIZU, K.SUNOSE, N.YAMAZAKI, K.TSURUO, T.SADAHIRO, S.MAKUUCHI, H.YAMORI, T., "Development and Characterization of a Model of Liver Metastasis Using Human Colon Cancer HCT-116", Biol. Pharm. Bull., (20070000), vol. 30, no. 9, pages 1779 - 1783
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.